All News
Filter News
Found 808,690 articles
-
Global Radiation Syndrome Treatment Market 2019-2023 | Increase in Nuclear Testing to Boost Demand | Technavio
11/21/2018
Technavio analysts forecast the global radiation syndrome treatment market to grow at a CAGR of over 6% during the forecast period, according to their latest market research report.
-
Ascentage Pharma to Present New Clinical Data at the ASH 2018 Annual Meeting
11/21/2018
Ascentage Pharma announced today that the Company will present clinical data of its novel BCR-ABL inhibitor HQP1351 in the upcoming 60th Annual Meeting of the American Society of Hematology (ASH)
-
Global Basel Cell Carcinoma Therapeutics Market 2018-2022 | Heavy Investments to Develop a Strong R&D Department Impacting the Market Growth | Technavio
11/21/2018
The global Basel cell carcinoma therapeutics market 2018-2022 is expected to post a CAGR of more than 5% during the forecast period, according to the latest market research report by Technavio.
-
InventHelp Inventor Develops Accessory for Individuals Experiencing a Sweaty/Sticky Groin Area (BMA-5294)
11/21/2018
- "I did a lot of walking and always felt my legs sticking together, feeling very sweaty," said an inventor from Lynn, Mass. "I checked the store shelves for something quick, discreet and portable; there was nothing. I thought there could be a better way to carry and use baby powder while on-the-go, so I invented this."
-
Amgen To Present At the Piper Jaffray And Evercore ISI Healthcare Conferences
11/21/2018
Amgen (NASDAQ:AMGN) will present at the Piper Jaffray Healthcare Conference at 8:30 a.m. ET on Tuesday, Nov. 27, 2018, in New York City and at the Evercore ISI Healthcare Conference at 11 a.m. ET on Wednesday, Nov. 28, 2018, in Boston. Elliott M. Levy, M.D., senior vice president of Global Development at Amgen, will present at the conferences.
-
EVIO Inc. Releases Preliminary Fourth Quarter 2018 Results
11/21/2018
EVIO Inc. ("EVIO" or the "Company"), (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry in North America, announced today unaudited analytical testing revenue for its fiscal 2018 fourth quarter ended September 30, 2018.
-
FDA Grants Priority Review for Daiichi Sankyo's New Drug Application for FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
11/21/2018
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for quizartinib for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia (AML).
-
Alzheimer's Foundation of America Advises Consumers: Be Informed before Using an At-Home Genetic Testing Kit this Holiday Season
11/21/2018
With the growing popularity of at-home genetic testing kits as holiday gifts, the Alzheimer's Foundation of America (AFA) is advising consumers about what to know before taking a genetic test to learn health information.
-
BerGenBio Appoints Cancer Drug Development Specialist Alan Barge MD as Interim Chief Medical Officer
11/21/2018
BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, oral, selective AXL kinase inhibitors for multiple cancer indications, is delighted to announce the appointment of Alan Barge MD as Interim Chief Medical Officer and member of the leadership team.
-
Ligand Announces OmniAb® Partnership with iMetabolic Biopharma Corporation
11/21/2018
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has entered into a worldwide OmniAb partnership with iMetabolic Biopharma Corporation (iMBP), an early stage biopharma company located in Tempe, AZ. Under the terms of the partnership, iMBP gains access to the full OmniAb platform including OmniRat®, OmniMouse®, OmniFlic® and OmniChicken™ in their drug discovery efforts.
-
Kolon TissueGene Doses First Patient in US Phase III Clinical Trial
11/21/2018
Kolon TissueGene, Inc. ("the Company"), a leader in advanced cell and gene therapies, announced today that it has dosed its first patient in its pivotal US Phase III clinical trials for Invossa, a cell and gene therapy in development for knee osteoarthritis (OA).
-
Court of Appeals for the Federal Circuit Lifts Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film
11/21/2018
Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated the preliminary injunction (PI) previously granted against Dr. Reddy's Laboratories (DRL) by the U.S. District Court for the District of New Jersey on July 13, 2018.
-
Sobeys Removes Romaine Lettuce Products from Shelves
11/21/2018
On Tuesday night, November 20, out of concern for the health of employees and customers, Sobeys Inc. temporarily stopped the sale of all Romaine lettuce products across its national store network until further notice.
-
Curaleaf Launches CBD Consumer Product Line
11/21/2018
Curaleaf, Inc. ("Curaleaf")(CSE: CURA) – one of the largest and fastest growing vertically integrated cannabis operators in the United States – today announced the launch of Curaleaf Hemp, a line of premium hemp-based CBD products.
-
Boston Scientific to Participate in the 30th Annual Piper Jaffray Healthcare Conference
11/21/2018
Boston Scientific Corporation (NYSE: BSX) will participate in the 30th Annual Piper Jaffray Healthcare Conference on Thursday, November 29, 2018 in New York City.
-
Silky Tots launches a U.S platform in response to thousands of requests from parents
11/21/2018
Today, Australian-born online store Silky Tots officially launches its U.S platform. Silky Tots make a beautiful range of luxe silk bedding for babies and young children that are not your average sheets and pillow cases
-
Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Pure Liquid Flavored Trio
11/21/2018
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® has released its new hemp-based CBD (cannabidiol) Kannaway® Pure Liquid Flavored Trio.
-
Donna Lynne Appointed to Key Leadership Role at Columbia University Irving Medical Center
11/21/2018
Donna Lynne, DrPH, has been named Senior Vice President and Chief Operating Officer, Columbia University Irving Medical Center (CUIMC), and Chief Executive Officer, ColumbiaDoctors, effective January 15, 2019.
-
Pulmatrix Announces Positive Final Results from the Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE™ Formulation of Itraconazole
11/21/2018
Pulmatrix, Inc. (NASDAQ: PULM) announced the results of the completed first-in-human study of Pulmazole (PUR1900) — an inhaled iSPERSETM formulation of the anti-fungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma.
-
InventHelp Inventor Develops Personal Care Tool (CKL-1144)
11/21/2018
"I wanted to create a better way to wash, scratch or apply lotion to the back and other hard-to-reach areas," said an inventor, from Chicago, Ill., "so I invented THE DANIEL'S BACK TOOL."